Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Factors Associated With Timing of Return to Intercourse After Obstetric Anal Sphincter Injuries.
Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
Waist-Height Ratio
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):23-34.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bayes Theorem
Benzimidazoles
Carboplatin
Female
Humans
Middle Aged
Neoadjuvant Therapy
Paclitaxel
Poly(ADP-ribose) Polymerase Inhibitors
Triple Negative Breast Neoplasms
authors with profiles
Olufunmilayo Olopade
Rita Nanda